The University of San Francisco is a private Jesuit university in San Francisco, California. The university's main campus is located on a 55-acre setting between the Golden Gate Bridge and Golden Gate Park. The main campus is nicknamed "The Hilltop" and is split into two sections.

During the past decade, University of San Francisco conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of San Francisco" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "Masimo Corporation" with 2 trials sponsored, "University of California, San Francisco" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Alain Algazi" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of San Francisco" #1 collaborator was "Alberta Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Child and Family Research Institute" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of San Francisco" are "Cancer" (2 trials), "Fabry Disease" (2 trials), "Healthy" (2 trials), "Action Tremor" (1 trials) and "BRAFV600E Melanoma Patients" (1 trials). Many other conditions were trialed in "University of San Francisco" in a lesser frequency.

Most popular intervention types in "University of San Francisco" are "Biological" (5 trials), "Device" (3 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ANS Totally Implantable Deep Brain Stimulation System" (1 trials), "Abiraterone acetate (AA)" (1 trials), "Atezolizumab" (1 trials), "BGC101 (autologous EnEPC preparation)" (1 trials) and "Control medium" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of San Francisco" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of San Francisco". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of San Francisco, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of San Francisco, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".